Dr. Christopher Richardson, MD

NPI: 1245573575
Total Payments
$10,451
2024 Payments
$10,300
Companies
4
Transactions
13
Medicare Patients
499
Medicare Billing
$29,651

Payment Breakdown by Category

Consulting$10,269 (98.3%)
Food & Beverage$182.27 (1.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $10,269 9 98.3%
Food and Beverage $182.27 4 1.7%

Top Paying Companies

Company Total Records Latest Year
Merck Sharp & Dohme LLC $10,269 9 $0 (2024)
Allergan Inc. $106.36 1 $0 (2017)
Incyte Corporation $58.59 2 $0 (2024)
Tactile Systems Technology Inc $17.32 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $10,300 10 Merck Sharp & Dohme LLC ($10,269)
2022 $27.51 1 Incyte Corporation ($27.51)
2021 $17.32 1 Tactile Systems Technology Inc ($17.32)
2017 $106.36 1 Allergan Inc. ($106.36)

All Payment Transactions

13 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/13/2024 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $3,489.00 General
Category: IMMUNOLOGY
11/11/2024 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $553.58 General
Category: IMMUNOLOGY
10/02/2024 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $2,500.00 General
Category: IMMUNOLOGY
10/02/2024 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $682.50 General
Category: IMMUNOLOGY
08/05/2024 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $814.45 General
Category: IMMUNOLOGY
05/15/2024 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $455.00 General
Category: IMMUNOLOGY
04/08/2024 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $682.50 General
Category: IMMUNOLOGY
03/11/2024 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $864.50 General
Category: IMMUNOLOGY
03/08/2024 Incyte Corporation OPZELURA (Drug) Food and Beverage Cash or cash equivalent $31.08 General
Category: Dermatology
02/07/2024 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $227.50 General
Category: IMMUNOLOGY
03/28/2022 Incyte Corporation OPZELURA (Drug) Food and Beverage Cash or cash equivalent $27.51 General
Category: Dermatology
10/27/2021 Tactile Systems Technology Inc Flexitouch Plus (Device), entre Food and Beverage In-kind items and services $17.32 General
Category: PNEUMATIC COMPRESSOR
03/02/2017 Allergan Inc. ACZONE (Drug) Food and Beverage In-kind items and services $106.36 General
Category: DERMATOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 226 311 $38,533 $11,131
2022 5 132 193 $21,939 $7,728
2021 2 76 105 $17,001 $6,676
2020 2 65 91 $13,655 $4,116
Total Patients
499
Total Services
700
Medicare Billing
$29,651
Procedure Codes
16

All Medicare Procedures & Services

16 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 66 90 $16,380 $5,931 36.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 48 49 $6,210 $2,132 34.3%
99451 Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes Facility 2023 51 51 $7,650 $1,308 17.1%
17000 Destruction of precancer skin growth, 1 growth Facility 2023 18 22 $2,556 $674.63 26.4%
17110 Destruction of skin growth, 1-14 growths Facility 2023 11 11 $2,057 $519.55 25.3%
11102 Biopsy of related skin growth, first growth Facility 2023 21 22 $3,080 $485.43 15.8%
17003 Destruction of precancer skin growth, 2-14 growths Facility 2023 11 66 $600.00 $80.13 13.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 51 69 $12,558 $4,740 37.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 42 43 $5,375 $1,941 36.1%
17000 Destruction of precancer skin growth, 1 growth Facility 2022 15 18 $1,998 $697.92 34.9%
11102 Biopsy of related skin growth, first growth Facility 2022 11 11 $1,540 $264.58 17.2%
17003 Destruction of precancer skin growth, 2-14 growths Facility 2022 13 52 $468.00 $84.66 18.1%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 42 68 $12,376 $5,021 40.6%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 34 37 $4,625 $1,655 35.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 20 40 $7,280 $2,514 34.5%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 45 51 $6,375 $1,602 25.1%

About Dr. Christopher Richardson, MD

Dr. Christopher Richardson, MD is a Nurse Practitioner healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2013. The National Provider Identifier (NPI) number assigned to this provider is 1245573575.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Richardson, MD has received a total of $10,451 in payments from pharmaceutical and medical device companies, with $10,300 received in 2024. These payments were reported across 13 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($10,269).

As a Medicare-enrolled provider, Richardson has provided services to 499 Medicare beneficiaries, totaling 700 services with total Medicare billing of $29,651. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Other Specialties Student in an Organized Health Care Education/Training Program, Dermatology
  • Location Rochester, NY
  • Active Since 04/04/2013
  • Last Updated 07/07/2023
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • NPI Number 1245573575

Products in Payments

  • ACZONE (Drug) $106.36
  • OPZELURA (Drug) $58.59
  • Flexitouch Plus (Device) $17.32

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Rochester